Efficacy and safety of tigecycline versus levofloxacin for community-acquired pneumonia
<p>Abstract</p> <p>Background</p> <p>Tigecycline, an expanded broad-spectrum glycylcycline, exhibits in vitro activity against many common pathogens associated with community-acquired pneumonia (CAP), as well as penetration into lung tissues that suggests effectiveness...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2009-09-01
|
Series: | BMC Pulmonary Medicine |
Online Access: | http://www.biomedcentral.com/1471-2466/9/44 |